Daily

Who makes verzenio?

Verzenio is Lilly ‘s first solid oral dosage form to be made using a faster, more efficient process known as continuous manufacturing. Continuous manufacturing is a new and advanced type of manufacturing within the pharmaceutical industry, and Lilly is one of the first companies to use this technology.

How is Verzenio used to treat breast cancer? Verzenio is used alone to treat women and men diagnosed with hormone-receptor-positive, HER2-negative metastatic or advanced-stage breast cancer if the cancer progressed after hormonal therapy treatment and earlier chemotherapy for metastatic disease. Verzenio is a pill taken by mouth. Learn more about:

Are there any side effects from taking Verzenio? Rare but severe lung inflammation: In some people, Verzenio may lead to severe pneumonia or interstitial lung disease. Interstitial lung disease describes a large group of conditions that cause scarring of the lungs. The scarring makes the lungs stiff, which makes it difficult to breathe.

When to use Verzenio in combination with Faslodex? Verzenio also is used in combination with Faslodex (chemical name: fulvestrant) to treat women diagnosed with hormone-receptor-positive, HER2-negative metastatic or advanced-stage breast cancer if the cancer grew after hormonal therapy treatment.

How long can you use the Verzenio savings card? The savings card program provides first 3 months of Verzenio for free, then the patient pays no more than $10 per month. The patient can use the savings card for up to 12 months ($25,000 annual cap). For more information, please visit www.verzenio.com .

What does Verzenio treat?

What does Verzenio treat? Verzenio (abemaciclib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Verzenio is used to treat advanced hormone-related breast cancer.

How did Verzenio get approved by the FDA? The FDA approved VERZENIO based on evidence from two clinical trials that enrolled women with HR-positive, HER2-negative advanced breast cancer. Patients in Trial 1 (NCT02107703) had an advanced breast cancer that progresed after hormone therapy.

When to use Verzenio in combination with Faslodex? Verzenio also is used in combination with Faslodex (chemical name: fulvestrant) to treat women diagnosed with hormone-receptor-positive, HER2-negative metastatic or advanced-stage breast cancer if the cancer grew after hormonal therapy treatment.

How does Verzenio work to control cancer cells? Cancer cells grow in uncontrolled fashion. Like Ibrance (chemical name: palbociclib) and Kisqali (chemical name: ribociclib), Verzenio is a cyclin-dependent kinase (CDK) 4/6 inhibitor. A kinase is a type of protein in the body that helps control cell division.